Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 6,457 shares at $7.51 ($48K) on 2024-09-27, disclosed to the SEC on 2024-10-01.
Scheduled sale ($48k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.46 | 6,162 | $46K | 95.4% |
| 2 | $7.51 | 295 | $2K | 4.6% |
| Total | $7.46 avg | 6,457 | $48K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |